LUCIAN MANU, M.D. is a board-certified psychiatrist, founder of the ManuMind Interventional Psychiatry – an expert interventional psychiatry research and clinical group, Clinical Assistant Professor of Psychiatry at Stony Brook University Renaissance School of Medicine, Director of Neuromodulation in the Department of Psychiatry and Behavioral Health and the Founding Director of the Stony Brook Treatment Resistant Mood Disorders Program - a research and clinical service dedicated to individuals with complex and difficult-to-treat mood and anxiety disorders. Dr. Manu earned his Doctor of Medicine degree from the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. He completed his psychiatry internship and residency at New York University Medical Center, where he later became a Clinical Instructor at the NYU Grossman School of Medicine. As the principal investigator for multiple pivotal research studies, Dr. Manu explores the synergy between novel therapies and devices such as Intranasal Ketamine and Esketamine, Intravenous and Intramuscular Ketamine, Transcranial Magnetic Stimulation (TMS), Vagus Nerve Stimulation (VNS), Electro Convulsive Therapy (ECT), Advanced Pharmacotherapies and Assisted Psychotherapies, for treating difficult-to-treat mood and anxiety disorders. His research has been published in peer reviewed journals including Brain Stimulation Journal, Journal of Affective Disorders, Neuropsychiatric Disease and Treatment, Nature Partner Journal Schizophrenia. He is also a member of the American Society of Ketamine Physicians and the Clinical TMS Society. 

LISA A. COTTONE, PhD is a research scientist and biopsychologist with over two decades of experience studying the brain mechanisms that influence sleep and waking behavior, addiction, and mental health. She earned her PhD in Biopsychology from Stony Brook University and completed her post-doctoral fellowship at Brookhaven National Laboratory, where she focused on how brain function changes across sleep and wake states, and how these changes relate to psychological health. Her work integrates advanced brain research tools—including EEG, event-related potentials, TMS, neuropsychological assessment and neuroimaging. Her peer-reviewed publications appear in leading journals such as The American Journal of Psychiatry, Neuroscience, and Drug and Alcohol Dependence, and she is a contributing author to the academic volume The Orbitofrontal Cortex. At ManuMind Interventional Psychiatry, Dr. Cottone applies her scientific insight to support a multidisciplinary approach to patient care, helping bridge the gap between neuroscience research and innovative psychiatric treatment.